Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis
NCT00285441 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2006-02-28
Summary
The purpose of this study is to identify differences in TB specific immune responses among immunosuppressed patients latently infected with TB and patients with active TB.
Conditions
- Tuberculosis
- HIV Infections
- Rheumatoid Arthritis
Sponsors & Collaborators
-
Copenhagen Hospital Corporation
collaborator OTHER -
The Danish Rheumatism Association
collaborator OTHER -
Danish Lung Association
collaborator OTHER -
Hvidovre University Hospital
lead OTHER
Principal Investigators
-
Morten Ruhwald, MD · University Hospital Hvidovre
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Completion
- 2008-09-30
Countries
- Denmark
Study Locations
More Related Trials
-
Characteristics of Tuberculosis Infection in Rheumatic Disease
NCT03736278 ·Status: COMPLETED
-
A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)
NCT01049282 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
NCT05027958 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TB and Sarcoidosis Granuloma
NCT06396910 ·Status: COMPLETED
-
Rapid Research in Diagnostics Development for TB Network
NCT04923958 ·Status: RECRUITING ·Phase: NA
-
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
NCT01269268 ·Status: COMPLETED
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
NCT03220464 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers for Therapy Response in Drug-resistant Tuberculosis
NCT02597621 ·Status: COMPLETED
-
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
NCT06796647 ·Status: RECRUITING
-
A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers
NCT00929396 ·Status: COMPLETED ·Phase: PHASE1
-
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT01685905 ·Status: UNKNOWN
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
NCT00925249 ·Status: UNKNOWN
-
Latent Tuberculosis Infection in Renal Transplant Recipients
NCT00682045 ·Status: COMPLETED
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
A Phase II Study of H56:IC31 in Healthy Adolescents
NCT03265977 ·Status: WITHDRAWN ·Phase: PHASE2
-
Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis
NCT01311999 ·Status: COMPLETED
-
Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients
NCT05841342 ·Status: UNKNOWN
-
A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine
NCT01003093 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
NCT02503839 ·Status: COMPLETED ·Phase: PHASE1
-
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
NCT00173264 ·Status: UNKNOWN
-
The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID
NCT02135289 ·Status: COMPLETED
-
Performance Evaluation of TB Breath- and Cough-testing Platforms
NCT03025516 ·Status: UNKNOWN